261
Views
3
CrossRef citations to date
0
Altmetric
Research Articles

Comprehensive analysis of the molecular docking of small molecule inhibitors to the Aβ1–40 peptide and its Osaka-mutant: insights into the molecular mechanisms of Aβ-peptide inhibition

, ORCID Icon & ORCID Icon
Pages 4536-4566 | Received 05 Aug 2019, Accepted 20 Oct 2019, Published online: 09 Dec 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Fahad M. Almutairi, Mohammad Rehan Ajmal, Mohammad Khursheed Siddiqi, Adel I. Alalawy & Rizwan Hasan Khan. (2022) On the binding reaction of loratadine with human serum acute phase protein alpha 1-acid glycoprotein. Journal of Biomolecular Structure and Dynamics 40:19, pages 9484-9491.
Read now

Articles from other publishers (2)

Sijia Hao, Yayu Yang, Ailing Han, Jianan Chen, Xiaoyu Luo, Guozhen Fang, Jifeng Liu & Shuo Wang. (2022) Glycosides and Their Corresponding Small Molecules Inhibit Aggregation and Alleviate Cytotoxicity of Aβ40. ACS Chemical Neuroscience 13:6, pages 766-775.
Crossref
Zhi-Kun Qiu, Zhi-Ting Liu, Jia-Li Pang, Han-Biao Wu, Xu Liu, Ze-Min Yang, Xiong Li & Ji-Sheng Chen. (2021) A network pharmacology study with molecular docking to investigate the possibility of licorice against posttraumatic stress disorder. Metabolic Brain Disease 36:7, pages 1763-1777.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.